Login

Axonics, Inc. 4/A SEC Filings

Filed On Filing
03 Oct 2023 Form 4/A: Dearen Danny L., President & CFO

Received 36,919 shares by exercise or conversion · Sold 18,684 shares ($902K)

14 May 2020 Form 4/A: Dearen Danny L., See Remarks

Received 4,147 shares by exercise or conversion ($4.06K) · Sold 4,147 shares ($153K)

14 May 2020 Form 4/A: Dearen Danny L., See Remarks

Received 15,853 shares by exercise or conversion ($15.5K) · Sold 15,853 shares ($587K)

14 May 2020 Form 4/A: Dearen Danny L., See Remarks

Received 20,103 shares by exercise or conversion · Sold 103 shares ($3.5K) · Sold 20,000 shares ($685K)

14 May 2020 Form 4/A: Dearen Danny L., See Remarks

Received 20,000 shares by exercise or conversion · Sold 20,000 shares ($629K)

15 Aug 2019 Form 4/A: Tammenoms Bakker Juliet, Director

Granted 3,333 Stock Option (Right to Buy)

15 Aug 2019 Form 4/A: Mcnamara Robert E, Director

Granted 3,333 Stock Option (Right to Buy)

15 Aug 2019 Form 4/A: Amble Erik, Director

Granted 3,333 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support